Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma
- PMID: 10854560
- DOI: 10.3892/or.7.4.871
Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma
Abstract
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an inhibitor of matrix metalloproteinase (MMP) in human carcinomas. TIMP-1 is thus considered to inhibit carcinoma invasion and metastasis. On the other hand, recent reports have disclosed that TIMP-1 also possesses a growth-promoting function. The clinical significance of TIMP-1 expression has not been fully determined in breast carcinoma. We thus examined the expression of TIMP-1 mRNA in tumor tissues of 100 breast carcinoma cases by a reverse transcriptase-polymerase chain reaction assay. The expression of TIMP-1 mRNA in each case was evaluated semi-quantitatively with adjustment for the TIMP-1 expression in a control breast carcinoma cell line, MCF7. There was a significant inverse correlation between the TIMP-1 expression and lymph node metastasis (p<0.05). A multivariate analysis disclosed that TIMP-1 expression status was an independent determinant factor for lymph node metastasis. In addition, the tumors with positive estrogen or progesterone receptors showed a higher TIMP-1 mRNA expression than those without the receptors, but this did not reach statistical significance. The findings suggest that the breast tumors with high TIMP-1 expression might show less malignant potential than those with low TIMP-1 expression.
Similar articles
-
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.Int J Cancer. 2000 Nov 15;88(4):575-8. doi: 10.1002/1097-0215(20001115)88:4<575::aid-ijc9>3.0.co;2-c. Int J Cancer. 2000. PMID: 11058873
-
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.Clin Cancer Res. 1997 Sep;3(9):1623-8. Clin Cancer Res. 1997. PMID: 9815852
-
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.Int J Cancer. 2008 May 1;122(9):2050-6. doi: 10.1002/ijc.23337. Int J Cancer. 2008. PMID: 18172859
-
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.Breast. 2013 Jun;22(3):330-4. doi: 10.1016/j.breast.2012.08.002. Epub 2012 Sep 18. Breast. 2013. PMID: 22995648
-
Clinical significance of MT1-MMP mRNA expression in breast cancer.Oncol Rep. 2001 Mar-Apr;8(2):401-3. doi: 10.3892/or.8.2.401. Oncol Rep. 2001. PMID: 11182063
Cited by
-
Proteomics analysis of serum from thymoma patients.Sci Rep. 2023 Mar 29;13(1):5117. doi: 10.1038/s41598-023-32339-4. Sci Rep. 2023. PMID: 36991043 Free PMC article.
-
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue.Mol Oncol. 2007 Sep;1(2):205-15. doi: 10.1016/j.molonc.2007.05.002. Epub 2007 May 21. Mol Oncol. 2007. PMID: 19383295 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous